CVE-2017-18228 describes a Cross-Site Scripting (XSS) vulnerability in the Remedy Mid Tier component of BMC Remedy AR System version 9.1. An attacker can exploit this by injecting malicious script into the ATTKey parameter within an arsys/servlet/AttachServlet request. Rated Medium with a CVSS score of 5.4, this vulnerability requires user interaction and low privileges, potentially leading to limited impact on confidentiality and integrity. There is no evidence of active exploitation, publicly available exploit code, or significant community discussion or media coverage for this CVE.
| Vendor | Product | Version(s) | CPE |
|---|---|---|---|
<= 9.1CPE matchmatch criteria | cpe:2.3:a:bmc:remedy_action_request_system:*:*:*:*:*:*:*:* |
CVSS version used by this source: 3.0
CVSS:3.0/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N
The average CVE in this peer group has 0.0 Twitter, 0.0 Reddit, 0.0 Bluesky, 0.0 Mastodon, and 0.1 GitHub mentions.
No media coverage found for this CVE.
The average CVE in this peer group has 0.0 InfoSec Media, 0.0 Vendor Blog, and 0.0 Security Researcher mentions.
Remediation records are not available for this CVE.